Ceramide in Stress Response

  • Mariana N. Nikolova-Karakashian
  • Krassimira A. Rozenova
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 688)


Evidence has consistently indicated that activation of sphingomyelinases and/or ceramide synthases and the resulting accumulation of ceramide mediate cellular responses to stressors such as lipopolysaccharide, interleukin 1ß, tumor necrosis factor a, serum deprivation, irradiation and various antitumor treatments. Recent studies had identified the genes encoding most of the enzymes responsible for the generation of ceramide and ongoing research is aimed at characterizing their individual functions in cellular response to stress. This chapter discusses the seminal and more recent discoveries in regards to the pathways responsible for the accumulation of ceramide during stress and the mechanisms by which ceramide affects cell functions. The former group includes the roles of neutral sphingomyelinase 2, serine palmitoyltransferase, ceramide synthases, as well as the secretory and endosomal/lysosomal forms of acid sphingomyelinase. The latter summarizes the mechanisms by which ceramide activate its direct targets, PKC?, PP2A and cathepsin D. The ability of ceramide to affect membrane organization is discussed in the light of its relevance to cell signaling. Emerging evidence to support the previously assumed notion that ceramide acts in a strictly structure-specific manner are also included. These findings are described in the context of several physiological and pathophysiological conditions, namely septic shock, obesity-induced insulin resistance, aging and apoptosis of tumor cells in response to radiation and chemotherapy.


Ceramide Synthesis Ceramide Content Ceramide Accumulation Ceramide Generation Serine Palmitoyltransferase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    GoÒi FM, Alonso A. Biophysics of sphingolipids I. Membrane properties of sphingosine, ceramides and other simple sphingolipids. Biochimica et Biophysica Acta (BBA)—Biomembranes 2006; 1758:1902–1921.Google Scholar
  2. 2.
    Zheng W, Kollmeyer J, Symolon H et al. Ceramides and other bioactive sphingolipid backbones in health and disease: Lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Biochimica et Biophysica Acta (BBA)—Biomembranes 2006; 1758:1864–1884.Google Scholar
  3. 3.
    Ramstedt B, Slotte JP. Sphingolipids and the formation of sterol-enriched ordered membrane domains. Biochimica et Biophysica Acta (BBA)—Biomembranes 2006; 1758:1945–1956.Google Scholar
  4. 4.
    Shaner RL, Allegood JC, Park H et al. Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers. J Lipid Res 2008.Google Scholar
  5. 5.
    Zhang J, Alter N, Reed JC et al. Bcl-2 interrupts the ceramide-mediated pathway of cell death. Proc Natl Acad Sci USA 1996; 93:5325–5328.PubMedGoogle Scholar
  6. 6.
    Jin J, Hou Q, Mullen TD et al. Ceramide generated by sphingomyelin hydrolysis and the salvage pathway is involved in hypoxia/reoxygenation-induced Bax redistribution to mitochondria in NT-2 cells. J Biol Chem 2008; 283:26509–26517.PubMedGoogle Scholar
  7. 7.
    Hernandez OM, Discher DJ, Bishopric NH et al. Rapid activation of neutral sphingomyelinase by hypoxia-reoxygenation of cardiac myocytes. Circ Res 2000; 86:198–204.PubMedGoogle Scholar
  8. 8.
    Basnakian AG, Ueda N, Hong X et al. Ceramide synthase is essential for endonuclease-mediated death of renal tubular epithelial cells induced by hypoxia-reoxygenation. Am J Physiol Renal Physiol 2005; 288:F308–314.PubMedGoogle Scholar
  9. 9.
    Yoshimura S, Banno Y, Nakashima S et al. Ceramide formation leads to caspase-3 activation during hypoxic PC12 cell death. Inhibitory effects of Bcl-2 on ceramide formation and caspase-3 activation. J Biol Chem 1998; 273:6921–6927.PubMedGoogle Scholar
  10. 10.
    Therade-Matharan S, Laemmel E, Carpentier S et al. Vicaut. Reactive oxygen species production by mitochondria in endothelial cells exposed to reoxygenation after hypoxia and glucose depletion is mediated by ceramide. Am J Physiol Regul Integr Comp Physiol 2005; 289:R1756–1762.PubMedGoogle Scholar
  11. 11.
    Yun JK, Kester M. Regulatory role of sphingomyelin metabolites in hypoxia-induced vascular smooth muscle cell proliferation. Arch Biochem Biophys 2002; 408:78–86.PubMedGoogle Scholar
  12. 12.
    Yu J, Novgorodov SA, Chudakova D et al. JNK3 signaling pathway activates ceramide synthase leading to mitochondrial dysfunction. J Biol Chem 2007; 282:25940–25949.PubMedGoogle Scholar
  13. 13.
    Bielawska AE, Shapiro JP, Jiang L et al. Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion. Am J Pathol 1997; 151:1257–1263.PubMedGoogle Scholar
  14. 14.
    Zager RA, Iwata M, Conrad DS et al. Altered ceramide and sphingosine expression during the induction phase of ischemic acute renal failure. Kidney Int 1997; 52:60–70.PubMedGoogle Scholar
  15. 15.
    Llacuna L, Mari M, Garcia-Ruiz C et al. Critical role of acidic sphingomyelinase in murine hepatic ischemia-reperfusion injury. Hepatology 2006; 44:561–572.PubMedGoogle Scholar
  16. 16.
    Singh I, Pahan K, Khan M et al. Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases. J Biol Chem 1998; 273:20354–20362.PubMedGoogle Scholar
  17. 17.
    Brogi A, Strazza M, Melli M et al. Induction of intracellular ceramide by interleukin-1 beta in oligodendrocytes. J Cell Biochem 1997; 66:532–541.PubMedGoogle Scholar
  18. 18.
    Schreur KD, Liu S. Involvement of ceramide in inhibitory effect of IL-1 beta on L-type Ca2+ current in adult rat ventricular myocytes. Am J Physiol 1997; 272:H2591–2598.PubMedGoogle Scholar
  19. 19.
    Kaszkin M, Huwiler A, Scholz K et al. Negative regulation of interleukin-1beta-activated neutral sphingomyelinase by protein kinase C in rat mesangial cells. FEBS Lett 1998; 440:163–166.PubMedGoogle Scholar
  20. 20.
    Nikolova-Karakashian M, Morgan ET, Alexander C et al. Bimodal regulation of ceramidase by interleukin-1beta. Implications for the regulation of cytochrome p450 2C11. J Biol Chem 1997; 272:18718–18724.PubMedGoogle Scholar
  21. 21.
    Chen J, Nikolova-Karakashian M, Merrill AH et al. Regulation of cytochrome P450 2C11 (CYP2C11) gene expression by interleukin-1, sphingomyelin hydrolysis and ceramides in rat hepatocytes. J Biol Chem 1995; 270:25233–25238.PubMedGoogle Scholar
  22. 22.
    Masamune A, Igarashi Y, Hakomori S. Regulatory role of ceramide in interleukin (IL)-1 beta-induced E-selectin expression in human umbilical vein endothelial cells. Ceramide enhances IL-1 beta action, but is not sufficient for E-selectin expression. J Biol Chem 1996; 271:9368–9375.PubMedGoogle Scholar
  23. 23.
    Sallusto F, Nicolo C, De Maria R et al. Ceramide inhibits antigen uptake and presentation by dendritic cells. J Exp Med 1996; 184:2411–2416.PubMedGoogle Scholar
  24. 24.
    Schneider C, Delorme N, El Btaouri H et al. Martiny. Interleukin 1 beta (IL-1 beta) action in porcine thyroid cells involves the ceramide signalling pathway. Cytokine 2001; 13:174–178.PubMedGoogle Scholar
  25. 25.
    Liu J, Ginis I, Spatz M et al. Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNF-alpha and ceramide. Am J Physiol Cell Physiol 2000; 278: C144–153.PubMedGoogle Scholar
  26. 26.
    Sawada M, Kiyono T, Nakashima S et al. Molecular mechanisms of TNF-alpha-induced ceramide formation in human glioma cells: P53-mediated oxidant stress-dependent and-independent pathways. Cell Death Differ 2004; 11:997–1008.PubMedGoogle Scholar
  27. 27.
    Kitatani K, Akiba S, Sato T. Ceramide-induced enhancement of secretory phospholipase A2 expression via generation of reactive oxygen species in tumor necrosis factor-alpha-stimulated mesangial cells. Cell Signal 2004; 16:967–974.PubMedGoogle Scholar
  28. 28.
    Garcia-Ruiz C, Colell A, Mari M et al. Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice. J Clin Invest 2003; 111:197–208.PubMedGoogle Scholar
  29. 29.
    Mallampalli RK, Peterson EJ, Carter AB et al. TNF-alpha increases ceramide without inducing apoptosis in alveolar type II epithelial cells. Am J Physiol 1999; 276: L481–490.PubMedGoogle Scholar
  30. 30.
    Ryan AJ, McCoy DM, McGowan SE et al. Alveolar sphingolipids generated in response to TNF-alpha modifies surfactant biophysical activity. J Appl Physiol 2003; 94:253–258.PubMedGoogle Scholar
  31. 31.
    Medler TR, Petrusca DN, Lee PJ et al. Apoptotic sphingolipid signaling by ceramides in lung endothelial cells. Am J Respir Cell Mol Biol 2008; 38:639–646.PubMedGoogle Scholar
  32. 32.
    Ishizuka N, Yagui K, Tokuyama Y et al. Kanatsuka. Tumor necrosis factor alpha signaling pathway and apoptosis in pancreatic beta cells. Metabolism 1999; 48:1485–1492.PubMedGoogle Scholar
  33. 33.
    Liu B, Andrieu-Abadie N, Levade T et al. Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death. J Biol Chem 1998; 273:11313–11320.PubMedGoogle Scholar
  34. 34.
    Luberto C, Hassler DF, Signorelli P et al. Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase. J Biol Chem 2002; 277:41128–41139.PubMedGoogle Scholar
  35. 35.
    Strelow A, Bernardo K, Adam-Klages S et al. Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death. J Exp Med 2000; 192:601–612.PubMedGoogle Scholar
  36. 36.
    Monney L, Olivier R, Otter I et al. Role of an acidic compartment in tumor-necrosis-factor-alpha-induced production of ceramide, activation of caspase-3 and apoptosis. Eur J Biochem 1998; 251:295–303.PubMedGoogle Scholar
  37. 37.
    Tsuji K, Mitsutake S, Yokose U et al. Role of ceramide kinase in peroxisome proliferator-activated receptor beta-induced cell survival of mouse keratinocytes. Febs J 2008; 275:3815–3826.PubMedGoogle Scholar
  38. 38.
    Zimmermann C, Ginis I, Furuya K et al. M. Hallenbeck. Lipopolysaccharide-induced ischemic tolerance is associated with increased levels of ceramide in brain and in plasma. Brain Res 2001; 895:59–65.PubMedGoogle Scholar
  39. 39.
    Lightle S, Tosheva R, Lee A et al. Elevation of ceramide in serum lipoproteins during acute phase response in humans and mice: role of serine-palmitoyl transferase. Arch Biochem Biophys 2003; 419:120–128.PubMedGoogle Scholar
  40. 40.
    Cuschieri J, Billgren J, Maier RV. Phosphatidylcholine-specific phospholipase C (PC-PLC) is required for LPS-mediated macrophage activation through CD14. J Leukoc Biol 2006; 80:407–414.PubMedGoogle Scholar
  41. 41.
    Claycombe KJ, Wu D, Nikolova-Karakashian M et al. Ceramide mediates age-associated increase in macrophage cyclooxygenase-2 expression. J Biol Chem 2002; 277:30784–30791.PubMedGoogle Scholar
  42. 42.
    Monick MM, Mallampalli RK, Carter AB et al. Ceramide regulates lipopolysaccharide-induced phosphatidylinositol 3-kinase and Akt activity in human alveolar macrophages. J Immunol 2001; 167:5977–5985.PubMedGoogle Scholar
  43. 43.
    Haimovitz-Friedman A, Cordon-Cardo C, Bayoumy S et al. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med 1997; 186:1831–1841.PubMedGoogle Scholar
  44. 44.
    Lei X, Zhang S, Bohrer A et al. The group VIA calcium-independent phospholipase A2 participates in ER stress-induced INS-1 insulinoma cell apoptosis by promoting ceramide generation via hydrolysis of sphingomyelins by neutral sphingomyelinase. Biochemistry 2007; 46:10170–10185.PubMedGoogle Scholar
  45. 45.
    Lu FG, Wong CS. Radiation-induced apoptosis of oligodendrocytes and its association with increased ceramide and down-regulated protein kinase B/Akt activity. Int J Radiat Biol 2004; 80:39–51.PubMedGoogle Scholar
  46. 46.
    Uchida Y, Nardo AD, Collins V et al. De novo ceramide synthesis participates in the ultraviolet B irradiation-induced apoptosis in undifferentiated cultured human keratinocytes. J Invest Dermatol 2003; 120:662–669.PubMedGoogle Scholar
  47. 47.
    Haimovitz-Friedman A, Kan CC, Ehleiter D et al. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med 1994; 180:525–535.PubMedGoogle Scholar
  48. 48.
    Sathishkumar S, Boyanovsky B, Karakashian AA et al. Elevated sphingomyelinase activity and ceramide concentration in serum of patients undergoing high dose spatially fractionated radiation treatment: implications for endothelial apoptosis. Cancer Biol Ther 2005; 4:979–986.PubMedGoogle Scholar
  49. 49.
    Grether-Beck S, Bonizzi G, Schmitt-Brenden H et al. Non-enzymatic triggering of the ceramide signalling cascade by solar UVA radiation. EMBO J 2000; 19:5793–5800.PubMedGoogle Scholar
  50. 50.
    Thomas RL Jr, Matsko CM, Lotze MT et al. Mass spectrometric identification of increased C16 ceramide levels during apoptosis. J Biol Chem 1999; 274:30580–30588.PubMedGoogle Scholar
  51. 51.
    Chatterjee M, Wu S. Cell line dependent involvement of ceramide in ultraviolet light-induced apoptosis. Mol Cell Biochem 2001; 219:21–27.PubMedGoogle Scholar
  52. 52.
    Zeidan YH, Wu BX, Jenkins RW et al. A novel role for protein kinase Cdelta-mediated phosphorylation of acid sphingomyelinase in UV light-induced mitochondrial injury. FASEB J 2008; 22:183–193.PubMedGoogle Scholar
  53. 53.
    Dai Q, Liu J, Chen J et al. Mitochondrial ceramide increases in UV-irradiated HeLa cells and is mainly derived from hydrolysis of sphingomyelin. Oncogene 2004; 23:3650–3658.PubMedGoogle Scholar
  54. 54.
    Charruyer A, Grazide S, Bezombes C et al. UV-C light induces raft-associated acid sphingomyelinase and JNK activation and translocation independently on a nuclear signal. J Biol Chem 2005; 280:19196–19204.PubMedGoogle Scholar
  55. 55.
    Zhou YT, Grayburn P, Karim A et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 2000; 97:1784–1789.PubMedGoogle Scholar
  56. 56.
    Adams JM 2nd, Pratipanawatr T, Berria R et al. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 2004; 53:25–31.PubMedGoogle Scholar
  57. 57.
    Turinsky J, O’Sullivan DM, Bayly BP. 1,2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo. J Biol Chem 1990; 265:16880–16885.PubMedGoogle Scholar
  58. 58.
    Holland WL, Brozinick JT, Wang LP et al. Summers. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-and obesity-induced insulin resistance. Cell Metab 2007; 5:167–179.PubMedGoogle Scholar
  59. 59.
    Deevska GM, Rozenova KA, Giltiay NV et al. Acid sphingomyelinase deficiency prevents diet-induced hepatic triacylglycerol accumulation and hyperglycemia in mice. J Biol Chem 2008.Google Scholar
  60. 60.
    Haus JM, Kashyap SR, Kasumov T et al. Plasma Ceramides Are Elevated in Obese Subjects with Type 2 Diabetes and Correlate with the Severity of Insulin Resistance. Diabetes 2008.Google Scholar
  61. 61.
    Shah C, Yang G, Lee I et al. Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1. J Biol Chem 2008; 283:13538–13548.PubMedGoogle Scholar
  62. 62.
    Samad F, Hester KD, Yang G et al. Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Diabetes 2006; 55:2579–2587.PubMedGoogle Scholar
  63. 63.
    Kolak M, Westerbacka J, Velagapudi VR et al. Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes 2007; 56:1960–1968.PubMedGoogle Scholar
  64. 64.
    Shimabukuro M, Zhou YT, Levi M et al. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci USA 1998; 95:2498–2502.PubMedGoogle Scholar
  65. 65.
    Fox TE, Han X, Kelly S et al. Diabetes alters sphingolipid metabolism in the retina: a potential mechanism of cell death in diabetic retinopathy. Diabetes 2006; 55:3573–3580.PubMedGoogle Scholar
  66. 66.
    Costantini C, Scrable H, Puglielli L. An aging pathway controls the TrkA to p75NTR receptor switch and amyloid beta-peptide generation. EMBO J 2006; 25:1997–2006.PubMedGoogle Scholar
  67. 67.
    Rodriguez-Calvo R, Serrano L, Barroso E et al. Peroxisome proliferator-activated receptor alpha down-regulation is associated with enhanced ceramide levels in age-associated cardiac hypertrophy. J Gerontol A Biol Sci Med Sci 2007; 62:1326–1336.PubMedGoogle Scholar
  68. 68.
    Wu D, Ren Z, Pae M et al. Aging up-regulates expression of inflammatory mediators in mouse adipose tissue. J Immunol 2007; 179:4829–4839.PubMedGoogle Scholar
  69. 69.
    Lightle SA, Oakley JI, Nikolova-Karakashian MN. Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging. Mech Ageing Dev 2000; 120:111–125.PubMedGoogle Scholar
  70. 70.
    Rutkute K, Karakashian AA, Giltiay NV et al. Aging in rat causes hepatic hyperresposiveness to interleukin-1beta which is mediated by neutral sphingomyelinase-2. Hepatology 2007; 46:1166–1176.PubMedGoogle Scholar
  71. 71.
    Smith AR, Visioli F, Frei B et al. Age-related changes in endothelial nitric oxide synthase phosphorylation and nitric oxide dependent vasodilation: evidence for a novel mechanism involving sphingomyelinase and ceramide-activated phosphatase 2A. Aging Cell 2006; 5:391–400.PubMedGoogle Scholar
  72. 72.
    Venable ME, Lee JY, Smyth MJ et al. Role of ceramide in cellular senescence. J Biol Chem 1995; 270:30701–30708.PubMedGoogle Scholar
  73. 73.
    Satoi H, Tomimoto H, Ohtani R et al. Astroglial expression of ceramide in Alzheimer’s disease brains: a role during neuronal apoptosis. Neuroscience 2005; 130:657–666.PubMedGoogle Scholar
  74. 74.
    Cutler RG, Kelly J, Storie K et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer’s disease. Proc Natl Acad Sci USA 2004; 101:2070–2075.PubMedGoogle Scholar
  75. 75.
    Han X, D MH, McKeel DW Jr et al. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer’s disease: potential role in disease pathogenesis. J Neurochem 2002; 82:809–818.PubMedGoogle Scholar
  76. 76.
    Jenkins GM, Cowart LA, Signorelli P et al. Acute activation of de novo sphingolipid biosynthesis upon heat shock causes an accumulation of ceramide and subsequent dephosphorylation of SR proteins. J Biol Chem 2002; 277:42572–42578.PubMedGoogle Scholar
  77. 77.
    Jana A, Pahan K. Oxidative stress kills human primary oligodendrocytes via neutral sphingomyelinase: implications for multiple sclerosis. J Neuroimmune Pharmacol 2007; 2:184–193.PubMedGoogle Scholar
  78. 78.
    Song JH, Shin SH, Ross GM. Oxidative stress induced by ascorbate causes neuronal damage in an in vitro system. Brain Res 2001; 895:66–72.PubMedGoogle Scholar
  79. 79.
    Song JH, Shin SH, Wang W et al. Involvement of oxidative stress in ascorbate-induced proapoptotic death of PC12 cells. Exp Neurol 2001; 169:425–437.PubMedGoogle Scholar
  80. 80.
    Goldkorn T, Balaban N, Shannon M et al. H2O2 acts on cellular membranes to generate ceramide signaling and initiate apoptosis in tracheobronchial epithelial cells. J Cell Sci 1998; 111 (Pt 21):3209–3220.PubMedGoogle Scholar
  81. 81.
    Yamada Y, Tian J, Yang Y et al. Oxidized low density lipoproteins induce a pathologic response by retinal pigmented epithelial cells. J Neurochem 2008; 105:1187–1197.PubMedGoogle Scholar
  82. 82.
    Auge N, Nikolova-Karakashian M, Carpentier S et al. Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase and sphingosine kinase. J Biol Chem 1999; 274:21533–21538.PubMedGoogle Scholar
  83. 83.
    Castillo SS, Levy M, Thaikoottathil JV et al. Reactive nitrogen and oxygen species activate different sphingomyelinases to induce apoptosis in airway epithelial cells. Exp Cell Res 2007; 313:2680–2686.PubMedGoogle Scholar
  84. 84.
    Park TS, Hu Y, Noh HL et al. Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. J Lipid Res 2008; 49:2101–2112.PubMedGoogle Scholar
  85. 85.
    Karpanen T, Bry M, Ollila HM et al. Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy. Circ Res 2008; 103:1018–1026.PubMedGoogle Scholar
  86. 86.
    Ichi I, Nakahara K, Miyashita Y et al. Association of ceramides in human plasma with risk factors of atherosclerosis. Lipids 2006; 41:859–863.PubMedGoogle Scholar
  87. 87.
    Wang H, Charles AG, Frankel AJ et al. Increasing intracellular ceramide: an approach that enhances the cytotoxic response in prostate cancer cells. Urology 2003; 61:1047–1052.PubMedGoogle Scholar
  88. 88.
    Scarlatti F, Sala G, Somenzi G et al. Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling. FASEB J 2003; 17:2339–2341.PubMedGoogle Scholar
  89. 89.
    Charles AG, Han TY, Liu YY et al. Taxol-induced ceramide generation and apoptosis in human breast cancer cells. Cancer Chemother Pharmacol 2001; 47:444–450.PubMedGoogle Scholar
  90. 90.
    Roberts CG, Gurisik E, Biden TJ et al. Synergistic cytotoxicity between tamoxifen and the plant toxin persin in human breast cancer cells is dependent on Bim expression and mediated by modulation of ceramide metabolism. Mol Cancer Ther 2007; 6:2777–2785.PubMedGoogle Scholar
  91. 91.
    Cabot MC, Han TY, Giuliano AE. The multidrug resistance modulator SDZ PSC 833 is a potent activator of cellular ceramide formation. FEBS Lett 1998; 431:185–188.PubMedGoogle Scholar
  92. 92.
    Wang H, Giuliano AE, Cabot MC. Enhanced de novo ceramide generation through activation of serine palmitoyltransferase by the P-glycoprotein antagonist SDZ PSC 833 in breast cancer cells. Mol Cancer Ther 2002; 1:719–726.PubMedGoogle Scholar
  93. 93.
    Senchenkov A, Han TY, Wang H et al. Enhanced ceramide generation and induction of apoptosis in human leukemia cells exposed to DT(388)-granulocyte-macrophage colony-stimulating factor (GM-CSF), a truncated diphtheria toxin fused to human GM-CSF. Blood 2001; 98:1927–1934.PubMedGoogle Scholar
  94. 94.
    Wang H, Maurer BJ, Reynolds CP et al. N-(4-hydroxyphenyl)retinamide elevates ceramide in neuroblastoma cell lines by coordinate activation of serine palmitoyltransferase and ceramide synthase. Cancer Res 2001; 61:5102–5105.PubMedGoogle Scholar
  95. 95.
    Gu X, Song X, Dong Y et al. Vitamin E succinate induces ceramide-mediated apoptosis in head and neck squamous cell carcinoma in vitro and in vivo. Clin Cancer Res 2008; 14:1840–1848.PubMedGoogle Scholar
  96. 96.
    Coroneos E, Wang Y, Panuska JR et al. Sphingolipid metabolites differentially regulate extracellular signal-regulated kinase and stress-activated protein kinase cascades. Biochem J 1996; 316 (Pt 1):13–17.PubMedGoogle Scholar
  97. 97.
    Merrill AH Jr, van Echten G, Wang E et al. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ. J Biol Chem 1993; 268:27299–27306.PubMedGoogle Scholar
  98. 98.
    Paumen MB, Ishida Y, Muramatsu M et al. Inhibition of Carnitine Palmitoyltransferase I Augments Sphingolipid Synthesis and Palmitate-induced Apoptosis. J Biol Chem 1997; 272:3324–3329.PubMedGoogle Scholar
  99. 99.
    Blazquez C, Galve-Roperh I, Guzman M. De novo-synthesized ceramide signals apoptosis in astrocytes via extracellular signal-regulated kinase. FASEB J 2000; 14:2315–2322.PubMedGoogle Scholar
  100. 100.
    Lehtonen JYA, Horiuchi M, Daviet L et al. Activation of the de novo Biosynthesis of Sphingolipids Mediates Angiotensin II Type 2†Receptor-induced Apoptosis. J Biol Chem 1999; 274:16901–16906.PubMedGoogle Scholar
  101. 101.
    Merrill AH Jr. De Novo Sphingolipid Biosynthesis: A Necessary, but Dangerous, Pathway. J Biol Chem 2002; 277:25843–25846.PubMedGoogle Scholar
  102. 102.
    Dickson RC. Thematic Review Series: Sphingolipids. New insights into sphingolipid metabolism and function in budding yeast. J Lipid Res 2008; 49:909–921.PubMedGoogle Scholar
  103. 103.
    Meier KD, Deloche O, Kajiwara K et al. Sphingoid base is required for translation initiation during heat stress in Saccharomyces cerevisiae. Mol Biol Cell 2006; 17:1164–1175.PubMedGoogle Scholar
  104. 104.
    Deng X, Yin X, Allan R et al. Ceramide Biogenesis Is Required for Radiation-Induced Apoptosis in the Germ Line of C. elegans. Science 2008; 322:110–115.PubMedGoogle Scholar
  105. 105.
    Jenkins GM. The emerging role for sphingolipids in the eukaryotic heat shock response. Cell Mol Life Sci 2003; 60:701–710.PubMedGoogle Scholar
  106. 106.
    Memon RA, Holleran WM, Moser AH et al. Endotoxin and Cytokines Increase Hepatic Sphingolipid Biosynthesis and Produce Lipoproteins Enriched in Ceramides and Sphingomyelin. Arterioscler Thromb Vasc Biol 1998; 18:1257–1265.PubMedGoogle Scholar
  107. 107.
    Shimabukuro M, Higa M, Zhou YT et al. Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J Biol Chem 1998; 273:32487–32490.PubMedGoogle Scholar
  108. 108.
    Pickersgill L, Litherland GJ, Greenberg AS et al. Key role for ceramides in mediating insulin resistance in human muscle cells. J Biol Chem 2007; 282:12583–12589.PubMedGoogle Scholar
  109. 109.
    Perry DK, Carton J, Shah AK et al. Serine Palmitoyltransferase Regulates de Novo Ceramide Generation during Etoposide-induced Apoptosis. J Biol Chem 2000; 275:9078–9084.PubMedGoogle Scholar
  110. 110.
    Bose R, Verheij M, Haimovitz-Friedman A et al. Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals. Cell 1995; 82:405–414.PubMedGoogle Scholar
  111. 111.
    Schissel SL, Tweedie-Hardman J, Rapp JH et al. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. J Clin Invest 1996; 98:1455–1464.PubMedGoogle Scholar
  112. 112.
    Walters MJ, Wrenn SP. Effect of sphingomyelinase-mediated generation of ceramide on aggregation of low-density lipoprotein. Langmuir 2008; 24:9642–9647.PubMedGoogle Scholar
  113. 113.
    Boyanovsky B, Karakashian A, King K et al. Uptake and metabolism of low density lipoproteins with elevated ceramide content by human microvascular endothelial cells: implications for the regulation of apoptosis. J Biol Chem 2003; 278:26992–26999.PubMedGoogle Scholar
  114. 114.
    Holland WL, Summers SA. Sphingolipids, Insulin Resistance and Metabolic Disease: New Insights from in Vivo Manipulation of Sphingolipid Metabolism. Endocr Rev 2008; 29:381–402.PubMedGoogle Scholar
  115. 115.
    Schmitz-Peiffer C, Craig DL, Biden TJ. Ceramide Generation Is Sufficient to Account for the Inhibition of the Insulin-stimulated PKB Pathway in C2C12 Skeletal Muscle Cells Pretreated with Palmitate. J Biol Chem 1999; 274:24202–24210.PubMedGoogle Scholar
  116. 116.
    Xu J, Yeh CH, Chen S et al. Involvement of de Novo Ceramide Biosynthesis in Tumor Necrosis Factor-alpha/ Cycloheximide-induced Cerebral Endothelial Cell Death. J Biol Chem 1998; 273:16521–16526.PubMedGoogle Scholar
  117. 117.
    Garzotto M, White-Jones M, Jiang Y et al. 12-O-tetradecanoylphorbol-13-acetate-induced apoptosis in LNCaP cells is mediated through ceramide synthase. Cancer Res 1998; 58:2260–2264.PubMedGoogle Scholar
  118. 118.
    Lehtonen JY, Horiuchi M, Daviet L et al. Activation of the de novo biosynthesis of sphingolipids mediates angiotensin II type 2 receptor-induced apoptosis. J Biol Chem 1999; 274:16901–16906.PubMedGoogle Scholar
  119. 119.
    Guzman M, Galve-Roperh I, Sanchez C. Ceramide: a new second messenger of cannabinoid action. Trends Pharmacol Sci 2001; 22:19–22.PubMedGoogle Scholar
  120. 120.
    Senkal CE, Ponnusamy S, Rossi MJ et al. Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas. Mol Cancer Ther 2007; 6:712–722.PubMedGoogle Scholar
  121. 121.
    Petrache I, Natarajan V, Zhen L et al. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med 2005; 11:491–498.PubMedGoogle Scholar
  122. 122.
    Park TS, Rosebury W, Kindt EK et al. Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice. Pharmacol Res 2008; 58:45–51.PubMedGoogle Scholar
  123. 123.
    Cuzzocrea S, Deigner HP, Genovese T et al. Inhibition of Ceramide Biosynthesis Ameliorates Pathological Consequences of Spinal Cord Injury. Shock 2008.Google Scholar
  124. 124.
    Guenther GG, Peralta ER, Rosales KR et al. Ceramide starves cells to death by downregulating nutrient transporter proteins. Proc Natl Acad Sci USA 2008; 105:17402–17407.PubMedGoogle Scholar
  125. 125.
    Scarlatti F, Bauvy C, Ventruti A et al. Ceramide-mediated Macroautophagy Involves Inhibition of Protein Kinase B and Up-regulation of Beclin 1. J Biol Chem 2004; 279:18384–18391.PubMedGoogle Scholar
  126. 126.
    Farrell AM, Uchida Y, Nagiec MM et al. UVB irradiation up-regulates serine palmitoyltransferase in cultured human keratinocytes. J Lipid Res 1998; 39:2031–2038.PubMedGoogle Scholar
  127. 127.
    Linn SC, Kim HS, Keane EM et al. Regulation of de novo sphingolipid biosynthesis and the toxic consequences of its disruption. Biochem Soc Trans 2001; 29:831–835.PubMedGoogle Scholar
  128. 128.
    Uhlinger DJ, Carton JM, Argentieri DC et al. Increased expression of serine palmitoyltransferase (SPT) in balloon-injured rat carotid artery. Thromb Haemost 2001; 86:1320–1326.PubMedGoogle Scholar
  129. 129.
    Min J, Mesika A, Sivaguru M et al. (Dihydro)ceramide synthase 1 regulated sensitivity to cisplatin is associated with the activation of p38 mitogen-activated protein kinase and is abrogated by sphingosine kinase 1. Mol Cancer Res 2007; 5:801–812.PubMedGoogle Scholar
  130. 130.
    Laviad EL, Albee L, Pankova-Kholmyansky I et al. Characterization of ceramide synthase 2: tissue distribution, substrate specificity and inhibition by sphingosine 1-phosphate. J Biol Chem 2008; 283:5677–5684.PubMedGoogle Scholar
  131. 131.
    Yabu T, Imamura S, Yamashita M et al. Identification of Mg2+-dependent neutral sphingomyelinase 1 as a mediator of heat stress-induced ceramide generation and apoptosis. J Biol Chem 2008; 283:29971–29982.PubMedGoogle Scholar
  132. 132.
    Marchesini N, Osta W, Bielawski J et al. Role for Mammalian Neutral Sphingomyelinase 2 in Confluence-induced Growth Arrest of MCF7 Cells. J Biol Chem 2004; 279:25101–25111.PubMedGoogle Scholar
  133. 133.
    Karakashian AA, Giltiay NV, Smith GM et al. Expression of neutral sphingomyelinase-2 (NSMase-2) in primary rat hepatocytes modulates IL-beta-induced JNK activation. FASEB J 2004; 18:968–970.PubMedGoogle Scholar
  134. 134.
    De Palma C, Meacci E, Perrotta C et al. Endothelial Nitric Oxide Synthase Activation by Tumor Necrosis Factor {alpha} Through Neutral Sphingomyelinase 2, Sphingosine Kinase 1 and Sphingosine 1 Phosphate Receptors: A Novel Pathway Relevant to the Pathophysiology of Endothelium. Arterioscler Thromb Vasc Biol 2006; 26:99–105.PubMedGoogle Scholar
  135. 135.
    Shirakabe K, Yamaguchi K, Shibuya H et al. TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase. J Biol Chem 1997; 272:8141–8144.PubMedGoogle Scholar
  136. 136.
    Verheij M, Bose R, Lin XH et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996; 380:75–79.PubMedGoogle Scholar
  137. 137.
    Westwick JK, Bielawska AE, Dbaibo G et al. Ceramide activates the stress-activated protein kinases. J Biol Chem 1995; 270:22689–22692.PubMedGoogle Scholar
  138. 138.
    Rutkute K, Karakashian AA, Giltiay NV et al. Aging in rat causes hepatic hyperresponsiveness to interleukin 1 b which is mediated by neutral sphingomyelinase-2. Hepatology (Baltimore, Md 2007; 46:1166–1176.Google Scholar
  139. 139.
    Chalfant CE, Kishikawa K, Mumby MC et al. Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A. Activation is stereospecific and regulated by phosphatidic acid. J Biol Chem 1999; 274:20313–20317.PubMedGoogle Scholar
  140. 140.
    Tellier E, Negre-Salvayre A, Bocquet B et al. Role for furin in tumor necrosis factor alpha-induced activation of the matrix metalloproteinase/sphingolipid mitogenic pathway. Mol Cell Biol 2007; 27:2997–3007.PubMedGoogle Scholar
  141. 141.
    Clarke CJ, Truong TG, Hannun YA. Role for neutral sphingomyelinase-2 in tumor necrosis factor alpha-stimulated expression of vascular cell adhesion molecule-1 (VCAM) and intercellular adhesion molecule-1 (ICAM) in lung epithelial cells: p38 MAPK is an upstream regulator of nSMase2. J Biol Chem 2007; 282:1384–1396.PubMedGoogle Scholar
  142. 142.
    Levade T, Malagarie-Cazenave S, Gouazé V et al. Ceramide in Apoptosis: A Revisited Role. Neurochemical Research 2002; 27:601–607.PubMedGoogle Scholar
  143. 143.
    Segui B, Cuvillier O, Adam-Klages S et al. Involvement of FAN in TNF-induced apoptosis. J Clin Invest 2001; 108:143–151.PubMedGoogle Scholar
  144. 144.
    Luberto C, Hassler DF, Signorelli P et al. Inhibition of Tumor Necrosis Factor-induced Cell Death in MCF7 by a Novel Inhibitor of Neutral Sphingomyelinase. J Biol Chem 2002; 277:41128–41139.PubMedGoogle Scholar
  145. 145.
    Corcoran CA, He Q, Ponnusamy S et al. Neutral sphingomyelinase-3 is a DNA damage and nongenotoxic stress-regulated gene that is deregulated in human malignancies. Mol Cancer Res 2008; 6:795–807.PubMedGoogle Scholar
  146. 146.
    Jayadev S, Liu B, Bielawska AE et al. Role for ceramide in cell cycle arrest. J Biol Chem 1995; 270:2047–2052.PubMedGoogle Scholar
  147. 147.
    Hayashi Y, Kiyono T, Fujita M et al. cca1 Is Required for Formation of Growth-arrested Confluent Monolayer of Rat 3Y1 Cells. J Biol Chem 1997; 272:18082–18086.PubMedGoogle Scholar
  148. 148.
    Marchesini N, Luberto C, Hannun YA. Biochemical Properties of Mammalian Neutral Sphingomyelinase2 and Its Role in Sphingolipid Metabolism. J Biol Chem 2003; 278:13775–13783.PubMedGoogle Scholar
  149. 149.
    Nikolova-Karakashian M, Karakashian A, Rutkute K. Role of neutral sphingomyelinases in aging and inflammation. Subcell biochem 2008; 49:469–486.PubMedGoogle Scholar
  150. 150.
    Rutkute K, Asmis RH, Nikolova-Karakashian MN. Regulation of neutral sphingomyelinase-2 by GSH: a new insight to the role of oxidative stress in aging-associated inflammation. J Lipid Res 2007; 48:2443–2452.PubMedGoogle Scholar
  151. 151.
    Kim WJ, Okimoto RA, Purton LE et al. Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias. Blood 2008; 111:4716–4722.PubMedGoogle Scholar
  152. 152.
    Hayashi Y, Kiyono T, Fujita M et al. cca1 Is Required for Formation of Growth-arrested Confluent Monolayer of Rat 3Y1 Cells. J Biol Chem 1997; 272:18082–18086.PubMedGoogle Scholar
  153. 153.
    Goswami R, Ahmed M, Kilkus J et al. Differential regulation of ceramide in lipid-rich microdomains (rafts): Antagonistic role of palmitoyl:protein thioesterase and neutral sphingomyelinase 2. J Neurosci Res 2005; 81:208–217.PubMedGoogle Scholar
  154. 154.
    Liu B, Hannun YA. Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione. J Biol Chem 1997; 272:16281–16287.PubMedGoogle Scholar
  155. 155.
    Gouaze V, Mirault ME, Carpentier S et al. Andrieu-Abadie. Glutathione peroxidase-1 overexpression prevents ceramide production and partially inhibits apoptosis in doxorubicin-treated human breast carcinoma cells. Mol Pharmacol 2001; 60:488–496.PubMedGoogle Scholar
  156. 156.
    Bello RI, Gomez-Diaz C, Buron MI et al. Enhanced anti-oxidant protection of liver membranes in long-lived rats fed on a coenzyme Q10-supplemented diet. Exp Gerontol 2005; 40:694–706.PubMedGoogle Scholar
  157. 157.
    Ayasolla K, Khan M, Singh AK et al. Inflammatory mediator and beta-amyloid (25–35)-induced ceramide generation and iNOS expression are inhibited by vitamin E Free Radic Biol Med 2004; 37:325–338.PubMedGoogle Scholar
  158. 158.
    Castillo SS, Levy M, Thaikoottathil JV et al. Reactive nitrogen and oxygen species activate different sphingomyelinases to induce apoptosis in airway epithelial cells. Exp Cell Res 2007; 313:2680–2686.PubMedGoogle Scholar
  159. 159.
    Martin SF, Sawai H, Villalba JM et al. Redox regulation of neutral sphingomyelinase-1 activity in HEK293 cells through a GSH-dependent mechanism. Arch Biochem Biophys 2007; 459:295–300.PubMedGoogle Scholar
  160. 160.
    Claus RA, Bunck AC, Bockmeyer CL et al. Role of increased sphingomyelinase activity in apoptosis and organ failure of patients with severe sepsis. FASEB J 2005; 19:1719–1721.PubMedGoogle Scholar
  161. 161.
    Wong ML, Xie B, Beatini N et al. Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: a possible link between inflammatory cytokines and atherogenesis. Proc Natl Acad Sci USA 2000; 97:8681–8686.PubMedGoogle Scholar
  162. 162.
    Gulbins E, Kolesnick R. Raft ceramide in molecular medicine. Oncogene 22:7070–7077.Google Scholar
  163. 163.
    Santana P, Pena LA, Haimovitz-Friedman A et al. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 1996; 86:189–199.PubMedGoogle Scholar
  164. 164.
    Morita Y, Tilly JL. Sphingolipid regulation of female gonadal cell apoptosis. Ann N Y Acad Sci 2000; 905:209–220.PubMedGoogle Scholar
  165. 165.
    Pena LA, Fuks Z, Kolesnick RN. Radiation-induced apoptosis of endothelial cells in the murine central nervous system: protection by fibroblast growth factor and sphingomyelinase deficiency. Cancer Res 2000; 60:321–327.PubMedGoogle Scholar
  166. 166.
    Cifone MG, De Maria R, Roncaioli P et al. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med 1994; 180:1547–1552.PubMedGoogle Scholar
  167. 167.
    Gulbins E, Bissonnette R, Mahboubi A et al. FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity 1995; 2:341–351.PubMedGoogle Scholar
  168. 168.
    Grassme H, Jekle A, Riehle A et al. CD95 signaling via ceramide-rich membrane rafts. J Biol Chem 2001; 276:20589–20596.PubMedGoogle Scholar
  169. 169.
    Cremesti A, Paris F, Grassme H et al. Ceramide enables fas to cap and kill. J Biol Chem 2001; 276:23954–23961.PubMedGoogle Scholar
  170. 170.
    Utermohlen O, Herz J, Schramm M et al. Fusogenicity of membranes: the impact of acid sphingomyelinase on innate immune responses. Immunobiology 2008; 213:307–314.PubMedGoogle Scholar
  171. 171.
    Schramm M, Herz J, Haas A et al. Utermohlen. Acid sphingomyelinase is required for efficient phago-lysosomal fusion. Cell Microbiol 2008; 10:1839–1853.PubMedGoogle Scholar
  172. 172.
    Ng CG, Griffin DE. Acid sphingomyelinase deficiency increases susceptibility to fatal alphavirus encephalomyelitis. J Virol 2006; 80:10989–10999.PubMedGoogle Scholar
  173. 173.
    Vit JP, Rosselli F. Role of the ceramide-signaling pathways in ionizing radiation-induced apoptosis. Oncogene 2003; 22:8645–8652.PubMedGoogle Scholar
  174. 174.
    Kroesen BJ, Jacobs S, Pettus BJ et al. BcR-induced apoptosis involves differential regulation of C16 and C24-ceramide formation and sphingolipid-dependent activation of the proteasome. J Biol Chem 2003; 278:14723–14731.PubMedGoogle Scholar
  175. 175.
    Wiegmann K, Schatze S, Machleidt T et al. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 1994; 78:1005–1015.PubMedGoogle Scholar
  176. 176.
    Bourbon NA, Sandirasegarane L, Kester M. Ceramide-induced Inhibition of Akt Is Mediated through Protein Kinase Czeta. Implications for Growth Arrest. J Biol Chem, 2002; 277:3286–3292.PubMedGoogle Scholar
  177. 177.
    Summers SA, Garza LA, Zhou H et al. Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol Cell Biol 1998; 18:5457–5464.PubMedGoogle Scholar
  178. 178.
    Powell DJ, Hajduch E, Kular G et al. Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCzeta-dependent mechanism. Mol Cell Biol 2003; 23:7794–7808.PubMedGoogle Scholar
  179. 179.
    Fox TE, Houck KL, O’Neill SM et al. Ceramide recruits and activates protein kinase C zeta (PKC zeta) within structured membrane microdomains. J Biol Chem 2007; 282:12450–12457.PubMedGoogle Scholar
  180. 180.
    Wang G, Silva J, Krishnamurthy K et al. Direct binding to ceramide activates protein kinase Czeta before the formation of a pro-apoptotic complex with PAR-4 in differentiating stem cells. J Biol Chem 2005; 280:26415–26424.PubMedGoogle Scholar
  181. 181.
    Pettus BJ, Chalfant CE, Hannun Y A. Ceramide in apoptosis: an overview and current perspectives. Biochim Biophys Acta 2002; 1585:114–125.PubMedGoogle Scholar
  182. 182.
    Heinrich M, Wickel M, Schneider-Brachert W et al. Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J 1999; 18:5252–5263.PubMedGoogle Scholar
  183. 183.
    Heinrich M, Neumeyer J, Jakob M et al. Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and-3 activation. Cell Death Differ 2004; 11:550–563.PubMedGoogle Scholar
  184. 184.
    Taha TA, Mullen TD, Obeid LM. A house divided: ceramide, sphingosine and sphingosine-1-phosphate in programmed cell death. Biochim Biophys Acta 2006; 1758:2027–2036.PubMedGoogle Scholar
  185. 185.
    Sawada M, Nakashima S, Banno Y et al. Ordering of ceramide formation, caspase activation and Bax/Bcl-2 expression during etoposide-induced apoptosis in C6 glioma cells. Cell Death Differ 2000; 7:761–772.PubMedGoogle Scholar
  186. 186.
    Ito T, Deng X, Carr B et al. Bcl-2 phosphorylation required for anti-apoptosis function. J Biol Chem 1997; 272:11671–11673.PubMedGoogle Scholar
  187. 187.
    Chalfant CE, Rathman K, Pinkerman RL et al. De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. J Biol Chem 2002; 277:12587–12595.PubMedGoogle Scholar
  188. 188.
    Sawada M, Kiyono T, Nakashima S et al. Molecular mechanisms of TNF-[alpha]-induced ceramide formation in human glioma cells:P53-mediated oxidant stress-dependent and-independent pathways. Cell Death Differ 2004; 11:997–1008.PubMedGoogle Scholar
  189. 189.
    Tepper AD, de Vries E, van Blitterswijk WJ et al. Ordering of ceramide formation, caspase activation and mitochondrial changes during CD95-and DNA damage-induced apoptosis. J Clin Invest 1999; 103:971–978.PubMedGoogle Scholar
  190. 190.
    Kashkar H, Wiegmann K, Yazdanpanah B et al. Acid sphingomyelinase is indispensable for UV light-induced Bax conformational change at the mitochondrial membrane. J Biol Chem 2005; 280:20804–20813.PubMedGoogle Scholar
  191. 191.
    Birbes H, Luberto C, Hsu YT et al. A mitochondrial pool of sphingomyelin is involved in TNFalpha-induced Bax translocation to mitochondria. Biochem J 2005; 386:445–451.PubMedGoogle Scholar
  192. 192.
    Rotolo JA, Zhang J, Donepudi M et al. Caspase-dependent and-independent Activation of Acid Sphingomyelinase Signaling. J Biol Chem 2005; 280:26425–26434.PubMedGoogle Scholar
  193. 193.
    Dbaibo GS, Pushkareva MY, Jayadev S et al. Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. Proceedings of the National Academy of Sciences of the United States of America 1995; 92:1347–1351.PubMedGoogle Scholar
  194. 194.
    Lee JY, Bielawska AE, Obeid LM. Regulation of Cyclin-Dependent Kinase 2 Activity by Ceramide. Exp Cell Res 2000; 261:303–311.PubMedGoogle Scholar
  195. 195.
    Venable ME, Bielawska A, Obeid LM. Ceramide Inhibits Phospholipase D in a Cell-free System. J Biol Chem 1996; 271:24800–24805.PubMedGoogle Scholar
  196. 196.
    Lee JY, Hannun YA, Obeid LM. Ceramide Inactivates Cellular Protein Kinase Calpha. J Biol Chem 1996; 271:13169–13174.PubMedGoogle Scholar
  197. 197.
    Westwick JK, Bielawska AE, Dbaibo G et al. Ceramide activates the stress-activated protein kinases. J Biol Chem 1995; 270:22689–22692.PubMedGoogle Scholar
  198. 198.
    Latinis KM, Koretzky GA. Fas ligation induces apoptosis and Jun kinase activation independently of CD45 and Lck in human T-cells. Blood 1996; 87:871–875.PubMedGoogle Scholar
  199. 199.
    Verheij M, Bose R, Lin XH et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996; 380:75–79.PubMedGoogle Scholar
  200. 200.
    Brenner B, Koppenhoefer U, Weinstock C et al. Fas-or Ceramide-induced Apoptosis Is Mediated by a Rac1-regulated Activation of Jun N-terminal Kinase/p38 Kinases and GADD153. J Biol Chem 1997; 272:22173–22181.PubMedGoogle Scholar
  201. 201.
    Bourbon NA, Yun J, Kester M. Ceramide Directly Activates Protein Kinase C zeta to Regulate a Stress-activated Protein Kinase Signaling Complex. J Biol Chem 2000; 275:35617–35623.PubMedGoogle Scholar
  202. 202.
    Shirakabe K, Yamaguchi K, Shibuya H et al. TAK1 Mediates the Ceramide Signaling to Stress-activated Protein Kinase/c-Jun N-terminal Kinase. J Biol Chem 1997; 272:8141–8144.PubMedGoogle Scholar
  203. 203.
    Strle K, Broussard SR, McCusker RH et al. C-jun N-terminal kinase mediates tumor necrosis factor-alpha suppression of differentiation in myoblasts. Endocrinology 2006; 147:4363–4373.PubMedGoogle Scholar
  204. 204.
    Rutkute K, Nikolova-Karakashian MN. Regulation of insulin-like growth factor binding protein-1 expression during aging. Biochem Biophys Res Commun 2007; 361:263–269.PubMedGoogle Scholar
  205. 205.
    Chen S, Lee JM, Zeng C et al. Amyloid beta peptide increases DP5 expression via activation of neutral sphingomyelinase and JNK in oligodendrocytes. J Neurochem 2006; 97:631–640.PubMedGoogle Scholar
  206. 206.
    Kolesnick RN, Goñi FM, Alonso A. Compartmentalization of ceramide signaling: physical foundations and biological effects. J Cell Physiol 2000; 184:285–300.PubMedGoogle Scholar
  207. 207.
    Gulbins E, Li PL. Physiological and pathophysiological aspects of ceramide. AJP—Regulatory, Integrative and Comparative Physiology 2006; 290:R11–26.PubMedGoogle Scholar
  208. 208.
    Miyaji M, Jin ZX, Yamaoka S et al. Okazaki and H. Umehara. Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis. J Exp Med 2005; 202:249–259.PubMedGoogle Scholar
  209. 209.
    Siskind LJ, Kolesnick RN, Colombini M. Ceramide Channels Increase the Permeability of the Mitochondrial Outer Membrane to Small Proteins. J Biol Chem 2002; 277:26796–26803.PubMedGoogle Scholar
  210. 210.
    Choudhury A, Sharma DK, Marks DL et al. Elevated endosomal cholesterol levels in Niemann-Pick cells inhibit rab4 and perturb membrane recycling. Mol Biol Cell 2004; 15:4500–4511.PubMedGoogle Scholar
  211. 211.
    Utermhlen O, Herz J, Schramm M et al. Fusogenicity of membranes: The impact of acid sphingomyelinase on innate immune responses. Immunobiology 2008; 213:307–314.Google Scholar
  212. 212.
    Merrill AH Jr, Jones DD. An update of the enzymology and regulation of sphingomyelin metabolism. Biochim Biophys Acta 1990; 1044:1–12.PubMedGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2010

Authors and Affiliations

  • Mariana N. Nikolova-Karakashian
    • 1
  • Krassimira A. Rozenova
    • 1
  1. 1.Department of PhysiologyUniversity of Kentucky College of MedicineLexington

Personalised recommendations